Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review
Xin Li, Yongcheng Song
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115772-115772
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Design, synthesis, and biological evaluation of first-in-class indomethacin-based PROTACs degrading SARS-CoV-2 main protease and with broad-spectrum antiviral activity
Jenny Desantis, Alessandro Bazzacco, Michela Eleuteri, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116202-116202
Open Access | Times Cited: 10
Terminalia chebula Retz. aqueous extract inhibits the Helicobacter pylori-induced inflammatory response by regulating the inflammasome signaling and ER-stress pathway
Ling Ou, Hengrui Liu, Xiaoyan Shi, et al.
Journal of Ethnopharmacology (2023) Vol. 320, pp. 117428-117428
Closed Access | Times Cited: 17
On the origins of SARS-CoV-2 main protease inhibitors
Yves L. Janin
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 81-118
Closed Access | Times Cited: 16
Synthesis and biological evaluation of novel peptidomimetic inhibitors of the coronavirus 3C-like protease
Franck Amblard, Julia C. LeCher, Ramyani De, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116263-116263
Closed Access | Times Cited: 6
Structure-based design of SARS-CoV-2 papain-like protease inhibitors
Prakash D. Jadhav, Bo Huang, J. Osipiuk, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 116011-116011
Open Access | Times Cited: 13
Design, Synthesis, X-ray Crystallography, and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease
Md Ashraf-Uz-Zaman, Teck Khiang Chua, Xin Li, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 2, pp. 715-731
Closed Access | Times Cited: 5
Synthesis and biological investigation of peptidomimetic SARS‐CoV‐2 main protease inhibitors bearing quinoline‐based heterocycles at P3
Sara Rossi, Graziano Deidda, Lia Fiaschi, et al.
Archiv der Pharmazie (2025) Vol. 358, Iss. 1
Closed Access
In Silico Tuning of Binding Selectivity for New SARS-CoV-2 Main Protease Inhibitors
Feng Wang, Vladislav Yu. Vasilyev
Computer Methods and Programs in Biomedicine (2025) Vol. 262, pp. 108678-108678
Open Access
Inhibitory efficacy and structural insights of Bofutrelvir against SARS-CoV-2 Mpro mutants and MERS-CoV Mpro
Weiwei Wang, Xuelan Zhou, Wen Li, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Targeting SARS-CoV-2 nonstructural protein 3: Function, structure, inhibition, and perspective in drug discovery
Xin Li, Yongcheng Song
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103832-103832
Open Access | Times Cited: 11
Synthesis, anti-inflammatory activity, and conformational relationship studies of chromone derivatives incorporating amide groups
Tao Xing, Shuyan Yu, Meng Qin, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 96, pp. 129539-129539
Closed Access | Times Cited: 10
Development of de-novo coronavirus 3-chymotrypsin-like protease (3CLpro) inhibitors since COVID-19 outbreak: A strategy to tackle challenges of persistent virus infection
Lei Tian, Taotao Qiang, Xiuding Yang, et al.
European Journal of Medicinal Chemistry (2023) Vol. 264, pp. 115979-115979
Closed Access | Times Cited: 9
Mask and Release Strategy‐Enabled Diversity‐Oriented Synthesis for DNA‐Encoded Library
Silin Zhang, Haiman Zhang, Xiawen Liu, et al.
Advanced Science (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 9
Synthesis, molecular docking analysis and in vitro evaluation of new heterocyclic hybrids of 4-aza-podophyllotoxin as potent cytotoxic agents
Ha Thanh Nguyen, Ket Tran Van, Hai Pham‐The, et al.
RSC Advances (2024) Vol. 14, Iss. 3, pp. 1838-1853
Open Access | Times Cited: 3
Iodine catalyzed synthesis of imidazo[1,2-a]pyrazine and imidazo[1,2-a]pyridine derivatives and their anticancer activity
Rajavenkatesh Krishnamoorthy, A. Parthiban
RSC Advances (2023) Vol. 13, Iss. 51, pp. 36439-36454
Open Access | Times Cited: 7
Exploiting high-energy hydration sites for the discovery of potent peptide aldehyde inhibitors of the SARS-CoV-2 main protease with cellular antiviral activity
Daniel W. Carney, Abba E. Leffler, Jeffrey A. Bell, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 103, pp. 117577-117577
Open Access | Times Cited: 2
Fufang Luohanguo Qingfei granules reduces influenza virus susceptibility via MAVS-dependent type I interferon antiviral signaling
Yu-Hui Lu, Min Wang, Jiuxiu Lin, et al.
Journal of Ethnopharmacology (2024) Vol. 324, pp. 117780-117780
Closed Access | Times Cited: 2
The Third CACHE Challenge – Finding Ligands Targeting the Macrodomain of SARS-CoV-2 NSP3 Using AI-inspired and Knowledge-Based Approaches.
Suneel Kumar B.V.S, Ophélie Rostaing, Mihai Burai Patrascu, et al.
(2024)
Open Access | Times Cited: 2
Thiophene-fused γ-lactams inhibit the SARS-CoV-2 main protease via reversible covalent acylation
Gayatri Tehlan, Lennart Brewitz, Lewis T. Ibbotson, et al.
Chemical Science (2024) Vol. 15, Iss. 20, pp. 7667-7678
Open Access | Times Cited: 2
Dopamine and its precursor levodopa inactivate SARS-CoV-2 main protease by forming a quinoprotein
Meng Hao, Yufeng He, Tingting Song, et al.
Free Radical Biology and Medicine (2024) Vol. 220, pp. 167-178
Closed Access | Times Cited: 2
Anticoronavirus activity of rhizome of Dryopteris crassirhizoma via multistage targeting of virus entry and viral proteases, Mpro and PLpro
Mobashira Habib, Young-Hee Jin, Yeon‐Hwa Kim, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118490-118490
Open Access | Times Cited: 2
The Dual Functions of Andrographolide in the Epstein–Barr Virus-Positive Head-and-Neck Cancer Cells: The Inhibition of Lytic Reactivation of the Epstein–Barr Virus and the Induction of Cell Death
Chukkris Heawchaiyaphum, Praphatson Malat, Chamsai Pientong, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15867-15867
Open Access | Times Cited: 5
Xiaoer niuhuang qingxin powder alleviates influenza a virus infection by inhibiting the activation of the TLR4/MyD88/NF-κB signaling pathway
Lanying Ma, Tong Wang, Meiyi Liu, et al.
Journal of Ethnopharmacology (2024) Vol. 328, pp. 118000-118000
Closed Access | Times Cited: 1
Structural basis of main proteases of coronavirus bound to Bofutrelvir
Weiwei Wang, Pei Zeng, Tongchao Liu, et al.
Journal of Molecular Biology (2024) Vol. 436, Iss. 22, pp. 168784-168784
Closed Access | Times Cited: 1
Crystal Structure of Inhibitor-Bound GII.4 Sydney 2012 Norovirus 3C-Like Protease
Alice-Roza Eruera, Alice M. McSweeney, Geena M. McKenzie-Goldsmith, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2202-2202
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top